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ABSTRACT
Bacteriophage phi29 utilizes a motor to translocate
genomic DNA into a preformed procapsid. The
motor contains six pRNAs, an enzyme and one
12-subunit connector with a central channel for
DNA transportation. A 20-residue peptide contain-
ing a His-tag was fused to the N-terminus of
the connector protein gp10. This fusion neither
interfered with procapsid assembly nor affected
the morphology of the prolate-shaped procapsid.
However, the pRNA binding and virion assembly
activity were greatly reduced. Such decreased
functions can be switched back on by the removal
of the tag via protease cleavage, supporting the
previous finding that the N-terminus of gp10 is
essential for the pRNA binding. The DNA-packaging
efficiency with dimeric pRNA was more seriously
affected by the extension than with monomeric
pRNA. It is speculated that the fusion of the tag
generated physical hindrance to pRNA binding, with
greater influence for the dimers than the monomers
due to their size. These results reveal a potential to
turn off and turn on the motor by attaching or
removing, respectively, a component to outer part of
the motor, and offers an approach for the inhibition
of viral replication by using a drug or a small peptide
targeted to motor components.
INTRODUCTION
The viral DNA-packaging motor of dsDNA bacteriophage
(e.g. phi29, lambda, T4 and T7) can translocate and compress
genomic DNA with tremendous velocity into a preformed
protein shell, called the procapsid, fueled by hydrolysis of
ATP during assembly (1–6). The procapsid of Bacillus sub-
tilis bacteriophage phi29 consists of the major capsid protein
gp8 (235 copies), connector protein gp10 (12 copies), head
ﬁber protein gp8.5 (55 copies) and the scaffolding protein
gp7 (180 copies) (7–9). Investigation of the bacterial virus
phi29 DNA-packaging motor revealed a molecule known
as pRNA (packaging RNA) that plays an essential role in
packaging DNA into procapsid (10). The pRNA contains
two functional domains (Figure 1A) (11,12). One domain,
composed of the central region of the pRNA, binds to the pro-
capsid. The other domain, which functions as a DNA translo-
cation domain, is located at the 50/30 paired ends. Six copies
of pRNA have been hypothesized to form a hexameric ring
via monomer to dimer and then hexamer (13–15) to drive
the DNA-packaging motor.
One of the essential components of the phi29 DNA-
packaging motor is the connector complex, which shows
a dodecameric cylindrical structure with a 3.6 nm central cha-
nnel through which viral genomic DNA is packaged into or
exits the procapsid during the viral life cycle. The detailed
structure of the phi29 portal connector protein gp10 has
been solved at the atomic resolution (16,17). The phi29 con-
nector ring consists of alpha-helical subunits, and three long
helices of each subunit form an inner channel. The wider end
of the connector is kept inside the procapsid, while the nar-
row end partially protrudes from the procapsid. Based upon
the structure, it is evident that the N-terminus protrudes
from the narrow end of the connector and the C-terminus
extends from the wider end of the connector (Figure 1B)
(16–20); therefore, the C-terminus is hidden within the pro-
capsid and the N-terminus is exposed to the solvent.
Recent DNA-packaging models proposed that the 5-fold
procapsid vertex and 12-fold connector (or the hexameric
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the relative motion of the two rings could produce a force
to drive the phi29 rotation motor to pack DNA (17,19–21).
Although the published DNA-packaging models all agree
that pRNA bound to one component to execute a consecutive
rotation (17,20,21), there were discrepancies regarding the
foothold for the pRNA. The recently published data (22)
suggest that the foothold for pRNA binding is the connector,
speciﬁcally, the N-terminus. Six copies of pRNA are bound
to the connector and work sequentially, so that the pRNA–
connector complex is part of the rotor (21).
In this study, we demonstrate that an additional 20 amino
acids fused to the N-terminus of gp10 did not morphologi-
cally affect procapsid assembly but blocked the binding
of pRNA to the His-procapsid. However, such diminished
function can be switched ‘on’ by the removal of the
20 amino acids via proteolytic cleavage with Tobacco Etch
Virus (TEV) protease. These results reveal a potential to
turn on and off the motor by attaching a component to the
N-terminus of the connector, and offers an approach for
the inhibition of viral replication using a drug or a small
peptide targeted to motor components for speciﬁc blockage
of DNA-packaging.
MATERIALS AND METHODS
Construction of plasmid pHis-gp7-8-8.5-10 for the
production of recombinant His-procapsid
Plasmid pHis-gp7-8-8.5-10 was constructed from two plas-
mids, pET-His-gp10 (23) and pARgp7-8-8.5 (24). Plasmid
pARgp7-8-8.5 was digested with BamH I and Bgl II, generat-
ing a DNA fragment containing gp7-8-8.5 with two cohesive
ends both compatible with Bgl II. This fragment was
inserted into the Bgl II site of pET-His-gp10, resulting in
a His-procapsid expression vector pHis-gp7-8-8.5-10.
Expression and purification of His-procapsid
To express and purify His-procapsid, an Escherichia coli
strain harboring the plasmid pHis-gp7-8-8.5-10 coding for
His-gp7-8-8.5-10 was inoculated into 5 ml Luria–Bertani
(LB) medium containing 100 mg/ml ampicillin and grown
overnight at 37 C with vigorous shaking (200 r.p.m.). Over-
night seed culture (5 ml) was inoculated into 500 ml LB
medium containing 100 mg/ml ampicillin and grown at
37 C with vigorous shaking, followed by 0.5 mM IPTG
induction for 3 h when OD600 reached 0.5–0.6. The cells
Figure 1. Schematic presentation of protease TEV cleavage site, V8 cleavage site at the N-terminus of connector in His-procapsid, primary sequences and
secondary structure of wild-type phenotype pRNA I-i0.( A) Primary sequences and predicted secondary structure of wild-type phenotype pRNA I-i0. Right and
left loops involved in hand-in-hand interaction are boxed and in boldface. Two functional domains are outlined. (B) TEV cleavage site, V8 cleavage site
and amino acid sequence at the N-terminal of His-gp10 as shown in a His-procapsid model. (C) Illustration for the formation of a pRNA dimer (A-b0) (B-a0) via
interlocking right and left loop. (D) Sequence in the right loop and left loop of individual specific pRNA.
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(Beckman) at 6500 r.p.m., 4 C for 15 min, and resuspended
in 25 ml lysate in buffer A (50 mM Tris–HCl, pH 8.0, 50 mM
NaCl, 1 mM EDTA, pH 8.0, 2 mM DTT and 1 mM PMSF).
Cell lysate was obtained by French Press at 10K psi twice,
followed by centrifugation at 10000 r.p.m. (JA-20, Beckman),
4 C for 30 min. The supernatant was loaded onto the step gra-
dient of 20–40% Optiprep and centrifuged at 40000 r.p.m.,
4 C for 12 h with a Ti45 rotor (Beckman). A thick band of
concentrated prohead cell lysate was collected and further
resuspended into TBE buffer (89 mM Tris–borate and
2 mM EDTA, pH 8.0) with 4-fold dilution, and then collected
by centrifugation at 35 000 r.p.m., 4 C for 2 h with a SW55
rotor (Beckman). The pellets were resuspended in 300 ml
TMS buffer (50 mM Tris–HCl, pH 7.8, 100 mM NaCl and
10 mM MgCl2), and sonicated for 40 s. The His-procapsid
was isolated by centrifugation in 10–30% (w/v) linear sucrose
gradients prepared in TMS buffer with a SW28 rotor (Beck-
man), at 25 000 r.p.m., 4 C for 4.5 h. After the His-procapsid
band was collected and the particles were spun down at
35 000 r.p.m., 4 C for 2 h with a SW55 rotor (Beckman),
and resuspended in 200 ml TMS buffer and sonicated for 40
s. Wild-type procapsid was also expressed and puriﬁed with
exactly the same procedure. The puriﬁed His-procapsid and
procapsid were conﬁrmed and quantiﬁed with 10% SDS–
PAGE.
Proteolytic treatment of His-procapsid
The puriﬁed His-procapsid was treated by TEV with an
enzyme/substrate molar ratio of  1:20 for 16 h at 4 C.
Procapsid was treated in the same manner as the His-
procapsid. The proteolytic efﬁciency was determined with
10% SDS–PAGE.
Electron microscopy of His-procapsid
Carbon-coated TEM grids were made hydrophilic by glow
discharge and ﬂoated for 1 min on drops of His-procapsid,
which were puriﬁed from a 10–30% sucrose gradient
centrifugation and resuspended in TMS. The grids were
negative-stained with 2% uranyl acetate. Electron micro-
graphs were taken on a Philips CM-100 transmission electron
microscope. Same procedures were used for TEV cleaved
His-procapsid and wild-type procapsid.
Synthesis of pRNA
The pRNA I-i0, A-a0, Sph I I-i0, Sph I A-a0, Sph I E-e0, Sph I
A-b0 and Sph I B-a0 were synthesized by in vitro transcription
with T7 RNA polymerase from a PCR-generated template, as
described previously (11,25,26). RNA with a preﬁx Sph I
is the RNA with a 26 base extension at the 30 end. Radio-
labeled pRNA such as [
3H]pRNA I-i0 and [
3H]pRNA A-a0
were prepared by including [
3H]UTP (Amersham) in the
transcription reaction.
Binding assays for pRNAs to His-procapsid
and procapsid
Binding assays were performed with sucrose gradient
sedimentation. A constant amount (8 mg) of puriﬁed His-
procapsid, TEV cleaved His-procapsid or procapsid, was
mixed with 100 ng of different types of
3H-labeled pRNA
([
3H]Sph I I-i0 and [
3H]pRNA A-a0) in TMS buffer, respec-
tively, and then dialyzed on a 0.25 mm VS ﬁlter membrane
(Millipore Corp.) against TBE buffer for 15 min at the ambi-
ent temperature. The mixtures containing procapsid (or His-
procapsid) and pRNA were further dialyzed against TMS
buffer for another 30 min at the ambient temperature and
then loaded onto a 5–20% sucrose gradient in TMS. After
35 min of centrifugation in a SW55 rotor (Beckman) at
35000 r.p.m. at the ambient temperature, fractions were
collected 10 drops each from the bottom of the tube and
subjected to liquid scintillation counting.
In vitro phi29 DNA-packaging and viral assembly to
determine the activity of His-procapsid
The in vitro assembly of phi29 virion with pRNA,
ATPase gp16, phi29 DNA-gp3, procapsid, and with supply
of ﬁnal 1 mM ATP in TMS buffer have been described
previously (27).
Determination of the requirement of pRNA for
DNA-packaging with His-procapsid
To conﬁrm the presence of the His-procapsid–pRNA com-
plex, it is necessary to remove free pRNA from the presumed
His-procapsid–pRNA complex. His-procapsid (15 mg) was
mixed with 500 ng pRNA of Sph I I-i0 in TMS buffer, and
then dialyzed on a 0.25 mm pore size type VS ﬁlter membrane
(Millipore Corp.) against TBE buffer for 15 min, followed by
dialysis against TMS buffer for another 30 min at ambient
temperature. The mixture was loaded onto a 5–20% sucrose
gradient in TMS. After 35 min of centrifugation in an
SW55 rotor (Beckman) at 35000 r.p.m. at 9 C, fractions cor-
responding to the presumed His-procapsids–pRNA complex
were collected and then loaded onto 4.5 ml 10% sucrose in
TMS buffer, the presumed His-procapsid–pRNA complex
were sedimented by ultracentrifugation in an SW55 rotor
(Beckman) at 35000 r.p.m. at 20 C for 2 h. The buffer con-
taining free pRNA was removed by aspiration carefully,
and the sedimented complex was resuspended in 50 ml
TMS buffer. The presumed His-procapsid–pRNAcomplex
were then treated with RNase A, or untreated, and used to
detect the virion assembly activity.
RESULTS
Plasmid construction, structural gene expression
and purification of recombinant His-procapsid
containing His-tagged connector protein gp10
Procapsid proteins gp7, gp8, gp8.5 and His-gp10 were co-
expressed in E.coli cells, harboring the plasmid pHis-gp7-8-
8.5-10. These proteins self-assembled into His-procapsid.
After puriﬁcation, the His-tagged procapsid was analyzed
with SDS–PAGE, revealing that all the procapsid structural
components gp7, gp8, gp8.5 and gp10 of the His-procapsid
were present with a similar ratio as compared to wild-type
phi29 procapsid. The molecular weight of gp7, gp8 and
gp8.5 were identical to the corresponding proteins in wild-
type procapsid, while His-gp10 showed higher molecular
weight than wild-type gp10 due to the 20 additional amino
acids (Figure 2). His-procapsid, His-procapsid cleaved by
5484 Nucleic Acids Research, 2006, Vol. 34, No. 19TEV and wild-type procapsid were examined by negative
stain electron microscopy. Results showed that there were no
signiﬁcant changes in the structure among them; all showed
the typical prolate-shape of phi29 procapsid (Figure 3), sug-
gesting that the His-procapsid possesses the same morphol-
ogy as procapsid assembled from untagged gp10 (Figure 3A).
Proteolytic treatment of His-procapsid generated
wild-type procapsid
In the procapsid, the C-terminus of gp10 is located at the
wider end of the connector that is buried within the procapsid,
while the N-terminus is located at the narrow end of the
connector that is exposed to the solvent. Protease TEV is
expected to cleave the His-tag that is fused with the TEV
recognition site proximal to the N-terminus of gp10
(Figure 1B). Treatment of His-procapsid with TEV resulted
in the removal of His-tag, producing a gp10 with molecular
weight similar to the gp10 from wild-type procapsid
(Figure 2). SDS-PAGE analysis of the protein proﬁle of
His-procapsid after TEV digestion conﬁrmed the cleavage
of His-gp10 into wild-type gp10, while no changes were
observed for the major capsid protein gp8, the ﬁber protein
gp8.5 and the scaffolding protein gp7 of the procapsid
(Figure 2). The results indicate that TEV cleaved His-
procapsid produced a procapsid with a normal connector
protein gp10 without affecting other capsid proteins.
The activities for pRNA binding, DNA-packaging and
virion assembly of His-procapsid were decreased for
His-procapsid compared to wild-type procapsid
The inhibition by the His-procapsid in pRNA binding was
clearly shown by sucrose gradient sedimentation. The puri-
ﬁed His-procapsid was incubated with [
3H]pRNA and then
subjected to 5–20% sucrose gradient sedimentation. Results
showed that the binding of pRNA to His-procapsid was
almost undetectable. No radioactive peak for His-procapsid–
pRNA complex could be found, while a peak representing the
normal procapsid–pRNA complex appeared and was centered
near fraction 22 when procapsid was mixed with [
3H]pRNA
(Figure 4).
An in vitro DNA-packaging system was used to test
whether the His-procapsid is functional in DNA translo-
cation. The results showed that the efﬁciency of DNA-
packaging into His-procapsid decreased only 2- to 5-fold
when using pRNA A-a0, Sph I A-a0, Sph I E-e0 or Sph I A-b0+
Sph I B-a0 in the packaging assay (Figures 5 and 6B). Viral
assembly activity of His-procapsid was assayed by plaque
formation analyzed with the highly sensitive phi29 assembly
system. It was found that phi29 assembly activity was
reduced more than 10-fold in the presence of an additional
20 amino acids at the N-terminus of the connector (Figure 7).
In conclusion, the insertion of a His-tag to the N-terminal
of gp10 signiﬁcantly interfered with the binding of pRNA
to procapsid, resulting in binding of pRNA to procapsid
almost undetectable (>99% reduction) by sucrose gradient
sedimentation (Figure 4). However, <5% reduction of DNA-
packaging activity was observed when pRNA I-i0 was used
(Figure 6B), and  10-fold reduction in viral assembly was
observed (Figure 8).
The activity for pRNA binding, DNA-packaging and
viral assembly activity of the His-procapsid were
restored after the removal of the 20 amino acids by
proteolytic cleavage
TEV cleavage of His-procapsid restored its activity for pRNA
binding (Figure 4). The diminished DNA-packaging activity
Figure 3. Electron micrographs of negative-stained procapsids. (A) His-procapsid. (B) His-procapsid cleaved with TEV. (C) Procapsid. Bar ¼ 200 nm.
Figure 2. SDS–PAGE (10%) profile of the His-procapsid before and after
TEV cleavage.
Nucleic Acids Research, 2006, Vol. 34, No. 19 5485was also switched on by the removal of the 20 amino acids
via proteolytic cleavage with TEV. After TEV cleavage the
DNA-packaging efﬁciency of the His-procapsid was found
to be similar to the activity of wild-type procapsid when
using pRNA I-i0, Sph I I-i0, pRNA A-a0, Sph I A-a0, Sph I
E-e0 or Sph I A-b0+ Sph I B-a0 in the packaging assay (Figure 5
and 6B). It was also found that the virion assembly activity
was restored after the removal of the 20 amino acids by
Figure 5. Sucrose gradient sedimentation (5–20%) to detect the binding of His-procapsid with [
3H]pRNA and the subsequent DNA-packaging using [
3H]pRNA
Sph I I-i0 and [
3H]phi29 DNA at the same time.
Figure 4. Sucrose gradient (5–20%) sedimentation to detect the binding of His-procapsid with
3H-labeled pRNA (A) I-i0;( B) A-a0.
5486 Nucleic Acids Research, 2006, Vol. 34, No. 19proteolytic cleavage. The activiy of His-procapsid increased
 10-fold after TEV cleavage.
The pRNA dimers suffered more seriously by
gp10 N-terminal extension than pRNA monomers in
DNA-packaging
Five different species of pRNA were used in the packaging
experiments (Figure 1D). The DNA-packaging activity of
pRNA A-a0, E-e0 and (A-b0) (B-a0) which exists almost as pure
dimer in solution (Figures 1C and 6A, lanes 1, 2, 5 and 8),
displayed greater inﬂuence for His-procapsid (Figure 6B,
lanes 4, 5, 12 and 16), in comparison to pRNA I-i0,o r
Sph I I-i0 (Figure 6B, lanes 2 and 3), which exist as a partial
monomer (Figure 6A, lanes 3 and 4) before assembly into
procapsid. Physically the pRNA dimer is longer than pRNA
monomer. The longer the polymer, the more it would be
affected by the barricade spatially and physically. We specu-
late that such decrease in packaging activity may be due
to the dramatically decreased binding efﬁciency between
pRNA and the connector. The physical hindrance by pRNA
size is greater for dimers than monomers, while the binding
to the connector was blocked by the extended tag. This
hindrance was removed and activity was restored after TEV
cleavage (Figure 6B, lanes 8, 9, 13 and 17). Coinciding
with DNA-packaging efﬁciency, His-procapsid also showed
higher assembly activity when the partially monomeric
pRNA I-i0 or Sph I I-i0 were used in the phi29 assembly
Figure 6. Comparison of DNA-packaging activity with pRNA dimer and monomer using His-procapsid. (A) Native gel assay (8%) for the efficiency in dimer
formation and (B) agarose gel assay for DNA-packaging efficiency.
Nucleic Acids Research, 2006, Vol. 34, No. 19 5487system (Figure 7). However, almost identical virion assembly
activity of pRNA dimers and monomers were observed after
the removal of His-tag from His-procapsid (Figure 7).
The pRNA is essential to DNA-packaging by
the His-procapsid
As noted, the DNA-packaging activity of the His-procapsid
was not affected by the His-tag insertion as seriously as
pRNA binding. The decrease in pRNA binding to His-
procapsid did not show direct correlation with inhibition of
phage assembly. This would raise a question of whether the
His-tagged procapsid requires the pRNA for DNA-packaging.
Further testing from the RNase digestion of the puriﬁed
procapsid/pRNA complex (Figure 8) reveals that virion
assembly was signiﬁcantly blocked after RNase digestion.
This is an indication that the pRNA is still required for the
DNA-packaging into the His-tagged procapsid.
DISCUSSION
It was found that fusion of 20 amino acids to the N-terminus
of each subunit of the connector protein gp10 did not
interfere with procapsid assembly and did not affect the
morphology of the prolate-shape procapsid, but the binding
of pRNA to the His-procapsid was dramatically decreased
and the assembly of phi29 virion was inhibited. However,
such decreased activity in pRNA binding and DNA-
packaging were restored via proteolytic cleavage with TEV.
This result implied that the amino acid residues or carried
charges at the N-terminus of the connector are critical for
Figure 7. Comparison of the virion assembly activity of His-procapsid before and after TEV cleavage with different pRNA in in vitro phi29 assembly system.
The inset is the assembly activity of His-procapsid with serial dilution before and after TEV cleavage using Sph I I-i0.
Figure 8. Assembly activity of His-procapsid–pRNA complex (after
purification in 10% sucrose gradient to remove free pRNA) treated with
RNase A. No assembly activity can be found after treated with RNase A.
5488 Nucleic Acids Research, 2006, Vol. 34, No. 19pRNA binding, this is in agreement with the recent ﬁnding
(22), which showed that the removal of the N-terminal
14 amino acids of the gp10 protein by proteolytic cleavage
resulted in undetectable binding of pRNA to either the
connector or the procapsid.
It was also shown that pRNA dimers suffer more seriously
from gp10 N-terminal extension than pRNA monomers in
DNA-packaging. The DNA-packaging activity of pRNA
dimer A-a0 (Figure 6A) showed greater inﬂuence in com-
parison to the partial monomer I-i0,o rSph I I-i0 (Figure 6A)
for His-procapsid. We propose that such a decrease in DNA-
packaging activity for His-procapsid compared to wild-type is
due to the physical barrier effect of an extended tag from the
connector, which blocked the binding of pRNA to the
N-terminus of the connector and generated greater hindrance
for pRNA dimers than monomers due to the size.
As noted, the insertion of a His-tag to the N-terminal
of gp10 signiﬁcantly interfered with the binding of pRNA
to procapsid, resulting in almost undetectable binding of
pRNA to procapsid by sucrose gradient sedimentation
(Figure 4). However, the DNA-packaging activity of the
His-procapsid was not affected by the N-terminal extensions
as seriously as pRNA binding. It is possible that the binding
of pRNA to the connector was less stable because of the
physical hindrance of an additional His-tag from the con-
nector. The binding was actually happening during the
DNA-packaging process when the motor was turning with
the supply of ATP as the energy source. However, when
the motor was not in the active mode, the complex of
pRNA/His-procapsid was much less stable than the pRNA/
procapsid complex that it may dissociate during the sucrose
gradient. The question of if the His-tagged procapsid requires
the pRNA for DNA packaging was answered by further test-
ing with RNase digestion (Figure 8), and the results showed
that the pRNA is still required for DNA-packaging of the His-
tagged procapsid. The other possible explanation for dispro-
portion between pRNA binding and DNA-packaging is that
the DNA-packaging activity was enhanced by the His-tag
insertion as long as pRNA binding occurred, a conclusion
deduced by the inhibition rate of pRNA binding and DNA-
packaging using the His-tagged procapsid. This conclusion
is not contradictory to the ﬁnding that phi29 assembly was
inhibited by the N-terminal extension (Figure 7). The connec-
tor is the junction between procapsid and the tail. It makes
sense that additional amino acids at the outer edge of the con-
nector could affect the assembly of the tail and subsequently
block the assembly of infectious virions.
The assembly of phi29 virion was inhibited by the
N-terminal extension of 20 amino acids, suggesting that fac-
tors involved in virion assembly can be targets for speciﬁc
antiviral treatment (28–30). For example, a chemical or
peptide targeting the motor components might block viral
DNA-packaging. Bacteriophage phi29 of B.subtilis is a linear
dsDNA virus for which the DNA-packaging process has been
studied in great detail. The commonality in DNA-packaging
among the linear dsDNA viruses, including dsDNA bacterio-
phages, adenoviruses, poxviruses, and herpes viruses, implies
a unique strategy of this approach for a novel drug design,
wherein the attachment of a small chemical or peptide to
the motor would result in speciﬁc blockage of DNA-
packaging. This principle also implies a strategy for gene
therapy to viral infection by expressing an extended subunit
of components of the viral DNA-packaging motor. RNA
viruses might use the motor to package their genomic RNA
as well (31,32).
CONCLUSION
Fusion of 20 amino acids to the N-terminus of each subunit
of the connector did not interfere with procapsid assembly
and did not affect the morphology of the prolate-shaped
procapsid, but dramatically affected the binding of pRNA
to the His-procapsid and the assembly of infectious virion.
However, normal motor activity was switched ‘on’ by the
removal of the 20 amino acids via proteolytic cleavage.
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